Citations

Mayo Clinic

Clear

424 citation(s) found for "Xu, Nan".

A 3D finite element model of prophylactic vertebroplasty in the metastatic spine: Vertebral stability and stress distribution on adjacent vertebrae
Salvatore, Giuseppe , Giambini, Hugo , Ciuffreda, Mauro , Thoreson, Andrew R. , An, Kai‐Nan , Thoreson, Andrew, Berton, Alessandra , Longo, Umile Giuseppe , Denaro, Vincenzo

The Journal of Spinal Cord Medicine | February 15, 2018 | Volume: 43 | Issue: 1 | Pages: 39-45

10.1080/10790268.2018.1432309 | PMID 29446706 Get It

ELASTICITY MEASUREMENTS BY SHEAR WAVE ELASTOGRAPHY: COMPARISON AND SELECTION OF SHEAR WAVE, RAYLEIGH WAVE AND LAMB WAVE THEORY
Xu, Hao , MO, JIAN-QIANG, Chen, Shigao , An, Kai‐Nan , Luo, Zong-Ping

Journal of Mechanics in Medicine and Biology | February 8, 2018 | Volume: 18 | Issue: 01 | Pages: 1750119

10.1142/s0219519417501196 Get It

Shear wave elastography (SWE) is a powerful method for the diagnosis of tissue disorders or degeneration based on tissue elasticity. In SWE application, it was recognized that the wave speed depends not only on the tissue elasticity but also on the structural shape, leading to different theoretical models. For liver, skin and myocardium, the appropriate theoretical model is known to be shear wave, Rayleigh wave and Lamb wave theory, respectively. Therefore, appropriate theoretical model should be adopted for the proper application of SWE. In this study, we verify these theoretical models in gelatin samples of different thicknesses, using experimental and numerical SWE tests. The results indicate that the wave speed was influenced by the ratio of the wavelength and sample thickness and the measurement region. Based on these results, the selection of theoretical model could be divided into three cases, and the appropriate theoretical model can be selected accordingly.
Contribution of the Ligamentum Teres to Hip Stability in the Presence of an Intact Capsule: A Cadaveric Study
Hooke, Alexander W. , An, Kai‐Nan , Trousdale, Robert T. , Jo, Suenghwan, Jo, Suenghwan , Sierra, Rafael J.

Arthroscopy | February 1, 2018 | Volume: 34 | Issue: 5 | Pages: 1480-1487

10.1016/j.arthro.2017.12.002 | PMID 29397288 Get It

Purpose To determine the contribution of the ligamentum teres (LT) to hip stability in the presence of an intact capsule with special attention to the change in range of motion and femoral head translation. Methods Seven fresh‐frozen cadaveric pelvises were used. Following visual inspection of the LT at different hip positions, internal rotation angles were measured at 10° of extension and at 0° of flexion, while external rotation was measured at 60°, 90°, and 110° of flexion with different hip abduction angles using electromagnetic motion tracking sensor. Femoral head translations were measured simultaneously. The tests were repeated after resection of the LT. The capsule was left intact for all test conditions. The results were compared between intact and LT resected conditions when torque of 2 and 4 Nm was applied. Results Compared with the intact hip, the LT resected hip showed no significant difference when 2 Nm torque was applied in all scenarios. With 4 Nm torque application, significant increase in external rotation was found at 60° and at 90° of flexion (1.7° ± 0.8° and 2.1° ± 1.0°, respectively). Significant difference was also noted at 60°, 90°, and 110° of flexion when the hip was in the adducted position while at 90° in the abducted hip. However, LT resection did not show significant change in internal rotation. There was no significant difference in the translation distance of the femoral head in the intact hip compared with the LT resected hip (0.77‐1.11 mm vs 0.79‐1.29 mm). Conclusions Our results indicate that within the physiologic range of motion, LT can minimally limit external rotation when the hip is in the flexed position but does not contribute to translation stability. Clinical Relevance In the hip with intact capsule, LT deficiency can result in a slight increase in range of motion, but its contribution to stability is questionable.
Are Clinical Certainty Ratings Helpful in the Diagnosis of Parkinson's Disease?
Gupta, Harsh , Mehta, Shyamal H. , Hentz, Joseph G. , Shill, Holly A. , Driver‐Dunckley, Erika, Belden, Christine M. , Beach, Thomas G. , Sue, Lucia I., Davis, Kathryn, Gupta, Harsh V, Driver-Dunckley, Erika, Adler, C H , Zhang, Nan , Driver‐Dunckley, Erika , Sabbagh, Marwan Noel , Dugger, Brittany N. , Serrano, Geidy E. , Adler, Charles H.

Movement Disorders Clinical Practice | January 15, 2018 | Volume: 5 | Issue: 2 | Pages: 165-170

10.1002/mdc3.12589 | PMID 30363433 Get It

AbstractBackgroundClinical diagnostic criteria for PD rely on rest tremor, bradykinesia, and rigidity. These features are non‐specific and neuropathological confirmation remains the gold standard for diagnosis. This study presents data on clinical certainty ratings in autopsy‐proven PD.MethodsSubjects were assessed annually by a movement disorders specialist and assigned to a clinical certainty group for PD based on multiple clinical features before autopsy. The three groups considered for analysis are as follows: Group I 0–49% certainty, Group II 50‐89% certainty, and Group III 90–100% certainty. All subjects were autopsied and had a standardized neuropathological assessment.Results275 subjects were assigned a PD certainty at their last visit before death. Group I had 80 subjects, Group II 56 subjects, and Group III 139 subjects. The clinical features recorded in Group I, II, and III, were as follows: rest tremor, bradykinesia, rigidity, postural instability, asymmetric onset, persistent asymmetry, current response to dopaminergic treatment, motor fluctuations, and dyskinesia. Rigidity, postural instability, asymmetric onset, current response to dopaminergic treatment, motor fluctuation, and dyskinesia were more likely to be present in the group which was rated with higher certainty. The final diagnosis of PD was confirmed by neuropathological assessment in 85% of the patients in Group III as compared to 30% in Group II and 5% in Group I.ConclusionsHigh certainty (90–100%) had strong positive predictive value (85%) for autopsy‐proven PD as compared to either lower certainty groups (0–49% and 50–89%) which had lower predictive value (5% and 30% respectively).
Residual Squamous Cell Carcinoma After Shave Biopsy in Solid Organ Transplant Recipients
Ilyas, Muneeb , Zhang, Nan , Sharma, Amit

Dermatologic Surgery | December 15, 2017 | Volume: 44 | Issue: 3 | Pages: 370-374

10.1097/dss.0000000000001340 | PMID 29517497 Get It

BACKGROUND After histopathological confirmation of a biopsy sample, cutaneous squamous cell carcinoma (cSCC) is often treated surgically; yet, residual tumor within the excision sample is not always found. The prevalence of residual cSCC after shave biopsy in solid organ transplant recipients (SOTRs) is unknown. OBJECTIVE Determine the prevalence of residual cSCC after shave biopsy in SOTRs. METHODS A retrospective case-controlled review was performed from a single center. Data were collected for 117 SOTRs and 117 age-matched nonimmunosuppressed controls diagnosed with shave biopsy–proven cSCC who underwent subsequent wide local excision from January 2004 to December 2016. Multivariable conditional logistic regression was used to determine variables associated with residual tumor in the combined population. Univariate logistic regression was used to investigate if transplant-related variables were associated with residual tumor in the SOTR group. RESULTS Of the 117 SOTRs, 57 (48.7%) had residual tumor within the excisional specimen. Of the 117 controls, 31 (26.5%) had residual tumor within the excisional specimen. Solid organ transplant recipients have 2.59 times greater odds of having residual cSCC after shave biopsy (95% confidence interval: 1.29–5.22, p = .0076). CONCLUSION Solid organ transplant recipients have a higher prevalence of residual cSCC after shave biopsy when compared with nonimmunosuppressed controls and should be prioritized for margin-controlled surgery.
Historical epidemiology of hepatitis C virus in select countries—volume 4
Vince, Adriana , Himatt, Sayed , Mohamed, Rosmawati , Opare‐Sem, Ohene , Workneh, A., Njouom, Richard , Ghazzawi, Imad, Abdulla, Maheeba , Kaliaskarova, Kulpash , Owusu‐Ofori, Shirley , Abdelmageed, Marwa , Adda, Danjuma, Baqali, A. Al, Dweik, N. Al, Ejji, Khalid Al, Kaabi, S. Al, Naamani, Khalid Al , Qamish, Jehad Al, Sadadi, M. Al, Salman, Jameela Al , AlBadri, M., Al‐Busafi, Said A. , Al‐Romaihi, Hamad Eid , Ampofo, William , Antonov, Krasimir , Anyaike, Chukwuma , Arome, F., Bane, Abate, Borodo, M. M., Brandon, S., Bright, Bisi , Butt, M. T., Cardenas, I., Chan, Henry Lik‐Yuen , Chen, C. J., Chen, Ding‐Shinn , Chen, Pei‐Jer , Cuellar, Diego , Derbala, M., Elbardiny, A. A., Estes, Chris , Farag, E., Gamkrelidze, Ivane , Garcìa, V. , Genov, J, Ghandour, Z., Ghuloom, M., Gómez, B. , Gunter, J., Habeeb, J., Hajelssedig, O. , Hamoudi, Waseem , Hrstić, Irena , Hu, Ching‐Chih , Huang, Chung‐Feng , Hui, Yee Tak , Jahis, Rohani, Jelev, Deian, John, Anil K , Kamel, Yasser , Kao, Jia‐Horng , Khamis, Jawad, Khattabi, H., Khoudri, Ibtissam , Конысбекова, А А , Kotzev, Iskren, Lai, Moon Sing, Lao, Wenyu, Layden, Jennifer E. , Lee, M. H., Lesi, Olufunmilayo , Li, M., Loo, Ching‐kong, Lukšić, Boris, Malu, Abraham O., Mateva, Lyudmila, Mitova, R, Morović, Miro, Murphy, K., Mustapha, B., Nde, H. , Nersesov, Alexander , Ngige, Evelyn, Njoya, Oudou, Nonković, Diana , Obekpa, Solomon, Oguche, Stephen , Okolo, Eucharia, Omede, O. , Omuemu, C., Phillips, Richard Odame , Prokopenko, Yuriy , Razavi, Homie , Razavi‐Shearer, Devin , Redae, Berhane, Reić, Tatjana, Wit, Tobias Rinke de, Ríos, Cielo , Robbins, S., Roberts, Lewis R. , Sanad, S. J., Schmelzer, Jonathan, Sharma, Manik , Simonova, Marieta, Su, Tung‐Hung , Sultan, K., Tan, S. S. , Tchernev, К., Tsang, O. T. Y., Tsang, S., Tzeuton, Christian, Ugoeze, S., Vi, R., Wani, Hamid, Yacoub, R., Yesmembetov, Kakharman, Youbi, M., Razavi‐Shearer, Kathryn , Wong, Grace Lai‐Hung , Roberts, Lewis R , Fung, James , Akın, Onur , Blach, Sarah , Chien, Rong‐Nan , Chuang, Wan‐Long , Lee, M.-H., Lo, Acy , Ondoa, Pascale , Wit, Tobias F. Rinke de , Robbins, S., Uzochukwu, Benjamin S C. , Wong, Vincent Wai‐Sun , Yuen, Man‐Fung , Lai-Hung Wong, Grace

Journal of Viral Hepatitis | November 4, 2017 | Volume: 24 | Issue: S2 | Pages: 8-24

10.1111/jvh.12762 | PMID 29105285 Get It

SummaryDue to the introduction of newer, more efficacious treatment options, there is a pressing need for policy makers and public health officials to develop or adapt national hepatitis C virus (HCV) control strategies to the changing epidemiological landscape. To do so, detailed, country‐specific data are needed to characterize the burden of chronic HCV infection. In this study of 17 countries, a literature review of published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates was conducted, and inputs were validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Hong Kong to 2.4% in Taiwan, while the largest viraemic populations were in Nigeria (2 597 000 cases) and Taiwan (569 000 cases). Diagnosis, treatment and liver transplant rates varied widely across the countries included in this analysis, as did the availability of reliable data. Addressing data gaps will be critical for the development of future strategies to manage and minimize the disease burden of hepatitis C.
The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4
Chan, Henry Lik‐Yuen , Chen, C. J., Omede, O. , Qamish, Jehad Al, Naamani, Khalid Al , Bane, Abate, Tan, S. S. , Simonova, Marieta, Cardenas, I., Derbala, Moutaz , Phillips, Richard Odame , Abdelmageed, Marwa , Abdulla, Maheeba , Adda, Danjuma, Baqali, A. Al, Dweik, N. Al, Ejji, Khalid Al, Ghazzawi, Imad, Kaabi, S. Al, Sadadi, M. Al, Salman, Jameela Al , AlBadri, M., Al‐Busafi, Said A. , Al‐Romaihi, Hamad Eid , Ampofo, William , Antonov, Krasimir , Anyaike, Chukwuma , Arome, F., Blach, Sarah , Borodo, M. M., Brandon, S., Bright, Bisi , Butt, M. T., Chen, Ding‐Shinn , Chen, Pei‐Jer , Cuellar, Diego , Elbardiny, A. A., Farag, Elmoubasher , Gamkrelidze, Ivane , Garcìa, V. , Genov, J, Ghandour, Z., Ghuloom, M., Gómez, B. , Gunter, J., Habeeb, J., Hajelssedig, O. , Hamoudi, Waseem , Himatt, Sayed , Hrstić, Irena , Hu, Ching‐Chih , Huang, Chung‐Feng , Hui, Yee Tak , Jahis, Rohani, Jelev, Deian, John, Anil K , Kaliaskarova, Kulpash , Kamel, Yasser , Kao, Jia‐Horng , Khamis, Jawad, Khattabi, H., Khoudri, Ibtissam , Конысбекова, А А , Kotzev, Iskren, Lai, Moon Sing, Lao, Wenyu, Layden, Jennifer E. , Lee, M. H., Lesi, Olufunmilayo , Li, M., Loo, Ching Kong, Lukšić, Boris, Maaroufi, Abderrahmane , Malu, Abraham O., Mateva, Lyudmila, Mitova, R, Mohamed, Rosmawati , Morović, Miro, Murphy, K., Mustapha, B., Nersesov, Alexander , Ngige, Evelyn, Njouom, Richard , Njoya, Oudou, Nonković, Diana , Obekpa, Solomon, Oguche, Stephen , Okolo, Eucharia, Omuemu, C., Opare‐Sem, Ohene , Owusu‐Ofori, Shirley , Prokopenko, Yuriy , Razavi, Homie , Razavi‐Shearer, Devin , Razavi‐Shearer, Kathryn , Redae, Berhane, Reić, Tatjana, Wit, Tobias Rinke de, Ríos, Cielo , Robbins, S., Roberts, Lewis R. , Sanad, S. J., Schmelzer, Jonathan, Sharma, Manik , Su, Tung‐Hung , Sultan, K., Tchernev, К., Tsang, O. T. Y., Tsang, Simon H. Y., Tzeuton, Christian, Ugoeze, S., Vi, R., Vince, Adriana , Wani, Hamid, Workneh, A., Yacoub, R., Yesmembetov, Kakharman, Youbi, M., Nde, H. , Wong, Grace Lai‐Hung , Blach, S , Roberts, Lewis R , Akın, Onur , Chien, Rong‐Nan , Chuang, Wan‐Long , Estes, Chris , Fung, James , Lee, M.-H., Lo, Acy , Ondoa, Pascale , Wit, Tobias F. Rinke de , Robbins, S., Uzochukwu, Benjamin S C. , Wong, Vincent Wai‐Sun , Yuen, Man‐Fung , Lai-Hung Wong, Grace

Journal of Viral Hepatitis | November 4, 2017 | Volume: 24 | Issue: S2 | Pages: 25-43

10.1111/jvh.12760 | PMID 29105283 Get It

SummaryFactors influencing the morbidity and mortality associated with viremic hepatitis C virus (HCV) infection change over time and place, making it difficult to compare reported estimates. Models were developed for 17 countries (Bahrain, Bulgaria, Cameroon, Colombia, Croatia, Dominican Republic, Ethiopia, Ghana, Hong Kong, Jordan, Kazakhstan, Malaysia, Morocco, Nigeria, Qatar and Taiwan) to quantify and characterize the viremic population as well as forecast the changes in the infected population and the corresponding disease burden from 2015 to 2030. Model inputs were agreed upon through expert consensus, and a standardized methodology was followed to allow for comparison across countries. The viremic prevalence is expected to remain constant or decline in all but four countries (Ethiopia, Ghana, Jordan and Oman); however, HCV‐related morbidity and mortality will increase in all countries except Qatar and Taiwan. In Qatar, the high‐treatment rate will contribute to a reduction in total cases and HCV‐related morbidity by 2030. In the remaining countries, however, the current treatment paradigm will be insufficient to achieve large reductions in HCV‐related morbidity and mortality.
Strategies to manage hepatitis C virus infection disease burden—Volume 4
Chen, Ding‐Shinn , Hamoudi, Waseem , Mustapha, B., Layden, Jennifer E. , Nersesov, Alexander , Reić, Tatjana, Garcìa, V. , Ríos, Cielo , Mateva, Lyudmila, Njoya, Oudou, Al‐Busafi, Said A. , Abdelmageed, Marwa , Abdulla, Maheeba , Adda, Danjuma, Baqali, A. Al, Dweik, N. Al, Ejji, Khalid Al, Ghazzawi, Imad, Kaabi, S. Al, Naamani, Khalid Al , Qamish, Jehad Al, Sadadi, M. Al, Salman, Jameela Al , AlBadri, M., Al‐Romaihi, Hamad Eid , Ampofo, William , Antonov, Krasimir , Anyaike, Chukwuma , Arome, F., Bane, Abate, Blach, Sarah , Borodo, M. M., Brandon, S., Bright, Bisi , Butt, M. T., Cardenas, I., Chan, Henry Lik‐Yuen , Chen, C. J., Chen, Pei‐Jer , Cuellar, Diego , Derbala, M., Elbardiny, A. A., Farag, E., Gamkrelidze, Ivane , Genov, J, Ghandour, Z., Ghuloom, M., Gómez, B. , Gunter, J., Habeeb, J., Hajelssedig, O. , Himatt, Sayed , Hrstić, Irena , Hu, Ching‐Chih , Huang, Chung‐Feng , Hui, Yee‐Tak, Jahis, Rohani, Jelev, Deian, John, Anil K , Kaliaskarova, Kulpash , Kamel, Yasser , Kao, Jia‐Horng , Khamis, Jawad, Khattabi, H., Khoudri, Ibtissam , Конысбекова, А А , Kotzev, Iskren, Lai, Moon Sing, Lao, Wenyu, Lee, M. H., Lesi, Olufunmilayo , Li, M., Loo, Ching‐kong, Lukšić, Boris, Maaroufi, Abderrahmane , Malu, Abraham O., Mitova, R, Mohamed, Rosmawati , Morović, Miro, Murphy, K., Nde, H. , Ngige, Evelyn, Njouom, Richard , Nonković, Diana , Obekpa, Solomon, Oguche, Stephen , Okolo, Eucharia, Omede, O. , Omuemu, C., Opare‐Sem, Ohene , Owusu‐Ofori, Shirley , Phillips, Richard Odame , Prokopenko, Yuriy , Razavi, Homie , Razavi‐Shearer, Devin , Razavi‐Shearer, Kathryn , Redae, Berhane, Wit, Tobias Rinke de, Robbins, S., Roberts, Lewis R. , Sanad, S. J., Sharma, Manik , Simonova, Marieta, Su, Tung‐Hung , Sultan, K., Tan, S. S. , Tchernev, К., Tsang, O. T. Y., Tsang, Simon H. Y., Tzeuton, Christian, Ugoeze, S., Vi, R., Vince, Adriana , Wani, Hamid, Workneh, A., Yacoub, R., Yesmembetov, Kakharman, Youbi, M., Schmelzer, Jonathan, Hui, Yee Tak , Wong, Grace Lai‐Hung , Blach, S , Roberts, Lewis R , Akın, Onur , Chien, Rong‐Nan , Chuang, Wan‐Long , Estes, Chris , Fung, James , Lee, M.-H., Lo, Acy , Ondoa, Pascale , Wit, Tobias F. Rinke de , Robbins, S., Uzochukwu, Benjamin S C. , Wong, Vincent Wai‐Sun , Yuen, Man‐Fung , Lai-Hung Wong, Grace

Journal of Viral Hepatitis | November 4, 2017 | Volume: 24 | Issue: S2 | Pages: 44-63

10.1111/jvh.12759 | PMID 29105286 Get It

SummaryThe hepatitis C virus (HCV) epidemic was forecasted through 2030 for 17 countries in Africa, Asia, Europe, Latin America and the Middle East, and interventions for achieving the Global Health Sector Strategy on viral hepatitis targets—“WHO Targets” (65% reduction in HCV‐related deaths, 90% reduction in new infections and 90% of infections diagnosed by 2030) were considered. Scaling up treatment and diagnosis rates over time would be required to achieve these targets in all but one country, even with the introduction of high SVR therapies. The scenarios developed to achieve the WHO Targets in all countries studied assumed the implementation of national policies to prevent new infections and to diagnose current infections through screening.
Abstract 5290: Racial variation in terminal duct lobular unit (TDLU) involution in Chinese and Polish breast cancer patients
Sung, Hyuna , Guo, Changyuan , Zheng, Shan , Li, Erni, Deng, Joseph , Gierach, Gretchen L. , Lü, Ning , Yang, Xiaohong R. , Guida, Jennifer , Li, Jing , Hu, Nan , García‐Closas, Montserrat , Figueroa, Jonine D. , Sherman, Mark E. , Gierach, Gretchen L

Cancer Research | July 31, 2017 | Volume: 77 | Issue: 13_Supplement | Pages: 5290-5290

10.1158/1538-7445.am2017-5290 Get It

Abstract Introduction: Terminal duct lobular unit (TDLU) involution, an age-related physiological process, is characterized by the reduction of size and numbers. Reduced involution is associated with higher mammographic density, a strong breast cancer risk factor. Both factors predict risk of developing breast cancer among women with benign disease. Given that prior studies have been conducted mainly in White women, we compared the extent of TDLU involution among Western and Asian breast cancer cases to describe potential racial heterogeneity in breast cancer etiology. Method: We obtained three TDLU involution metrics (count/100 mm2, mean span, and mean acini count/TDLU; all inversely correlated with TDLU involution) measured in benign breast tissue sections from 379 Chinese (254 luminal A and 125 core basal phenotype [CBP] cases) and 476 Polish (407 luminal A and 69 CBP) breast cancer cases. Polytomous logistic regression was performed using tertiles of TDLU measures as ordinal dependent variable and race as an independent variable. Covariates included age, body mass index, and parity. Analyses were performed separately by age group (<50, ≥50) and subtype (luminal A and CBP). Results: Among luminal A cases, Chinese had significantly greater TDLU count compared with Polish in both age groups (ORtrend= 11.0; 95% CI=2.80-43.2; Ptrend=0.001 for age<50; ORtrend= 12.1; 95% CI=5.12-28.7; Ptrend=1E-08 for age≥50). In addition, Chinese were more likely to have greater mean span and acini count among younger cases (ORtrend=2.5; 95% CI=1.44-4.28; Ptrend=0.001 for mean span and ORtrend=7.4; 95% CI=4.13-13.4; Ptrend=3E-11 for acini count) but not among older cases. Among CBP cases, Chinese were more likely to have greater acini count compared to Polish only among younger women (ORtrend=2.6; 95% CI=1.12-6.95; Ptrend=0.03 for age<50). Conclusion: We found Chinese were more likely to have reduced TDLU involution compared to Polish cases after accounting for potential confounders, with greater differences for luminal A and younger women. Studies of TDLU involution in diverse populations are needed to confirm and understand whether population difference in TDLU involution metrics are related to age at breast cancer onset and risks for specific tumor subtypes. Citation Format: Hyuna Sung, Changyuan Guo, Jennifer Guida, Shan Zheng, Erni Li, Jing Li, Nan Hu, Joseph Deng, Montserrat Garcia-Closas, Jonine Figueroa, Mark Sherman, Gretchen Gierach, Ning Lu, Xiaohong R. Yang. Racial variation in terminal duct lobular unit (TDLU) involution in Chinese and Polish breast cancer patients [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 5290. doi:10.1158/1538-7445.AM2017-5290
Ultrasound elastography for carpal tunnel pressure measurement: A cadaveric validation study
Kubo, Kazutoshi, Zhou, Boran , Cheng, Yu‐Shiuan, Yang, Tai‐Hua , Qiang, Bo, An, Kai‐Nan, Moran, Steven L. , Amadio, Peter C. , Zhang, Xiaoming , Zhao, Chunfeng , An, Kai‐Nan , Zhang, Xiaoming

Journal of Orthopaedic Research | July 21, 2017 | Volume: 36 | Issue: 1 | Pages: 477-483

10.1002/jor.23658 | PMID 28731271 Get It

ABSTRACT Carpal tunnel pressure is a key factor in the etiology of carpal tunnel syndrome. Numerous approaches have been conducted to measure carpal tunnel pressure. However, most techniques are invasive and take time and effort. We have developed an innovative approach to noninvasively assess the tunnel pressure by using the ultrasound surface wave elastography (USWE) technique. In a previous study it was shown that the shear wave speed in a tendon increased linearly with increasing tunnel pressure enclosed the tendon in a simple tendon model. This study aimed to examine the relationship between the carpal tunnel pressure and the shear wave speeds inside and outside the carpal tunnel in a human cadaveric model. The result showed that the shear wave speed inside the carpal tunnel increased linearly with created carpal tunnel pressure, while the shear wave speed outside the carpal tunnel remained constant. These findings suggest that noninvasive measurement of carpal tunnel pressure is possible by measuring the shear wave speed in the tendon. After fully establishing this technology and being applicable in clinic, it would be useful in the diagnosis of carpal tunnel syndrome. For that reason, further validation with this technique in both healthy controls and patients with carpal tunnel syndrome is required. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:477–483, 2018.